Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion
Date:7/29/2011
reflects a decrease in dose utilization due to implementation of the bundled payment system, offset slightly by patient population growth. The Company announced that it expects an additional decrease in dose utilization related to label changes and reimbursement changes proposed by the Centers for Medicare & Medicaid Services, should the proposal be implemented as drafted. If implemented, in aggregate, the Company expects dose utilization would decline in 2011 as compared to 2010 by 20 to 25 percent, offset partially by patient population growth and an increase in the average net sales price. The Company believes that the majority of the dose utilization changes will be implemented by the end of 2011 with some residual impact early in 2012. The Company also believes that mean hemoglobin levels will remain above 10 g/dL in the dialysis setting.
Combined Neulasta® (pegfilgrastim) and NEUPOGEN® (Filgrastim) sales increased 13 percent to $1,326 million in the second quarter of 2011 versus $1,174 million in the second quarter of 2010. Combined U.S. Neulasta and NEUPOGEN sales increased 15 percent to $999 million in the second quarter of 2011 versus $868 million in the second quarter of 2010, driven primarily by increases in unit demand and the average net sales price. Approximately half of the unit demand increase reflects underlying Neulasta demand growth including increased first cycle penetration due to uses of newer, more myelosuppressive chemotherapy regimens. The remaining unit demand growth was primarily driven by the timing of customer orders. Combined international Neulasta and NEUPOGEN sales increased 7 percent to $327 million in the second quarter of 2011 versus $306 million in the second quarter of 2010. Excluding the $14 million favorable impact of foreign exchange, combined international Neulasta and NEUPOGEN sales increased 2 percent reflecting growth in Neulasta due, in part, to continued conv
'/>"/>
| SOURCE Amgen Copyright©2010 PR Newswire. All rights reserved |
Related medicine technology :
1. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
2. Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
3. Amgen’s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
4. Spherix Reports Second Quarter Earnings
5. Tapestry Reports Second Quarter 2007 Results
6. Callisto Reports on Second-Quarter 2007 Milestones
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
Post Your Comments:
(Date:5/22/2013)... YORK , May 22, 2013 The Lupus ... conference devoted to advancing new treatments for lupus nephritis, ... 60 percent of patients. The conference launched a new ... the Lupus Nephritis Trials Network (LNTN). More ... and the kidney came together to focus on two ...
(Date:5/22/2013)... May 22, 2013 Modern Medical announced today ... Launched in November 2012 in a test phase, ... to stop the rising opioid abuse in the ... program designed to protect employees, physicians and employers ... necessary balance to provide pain relief for the ...
(Date:5/22/2013)... , May 22, 2013 MGT Capital Investments, Inc. ... present at the Second Annual Marcum LLP MicroCap Conference ... York City at the Grand Hyatt Hotel. ... Executive Officer, will update investors and answer questions. ... Company,s presentation is scheduled to begin at 9:30 a.m. ...
Breaking Medicine Technology:Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis 2Modern Medical Introduces Opioid Abuse Solution to the Workers' Compensation Industry 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4... Kosan Biosciences,Incorporated (Nasdaq: KOSN ) today announced ... lead Hsp90 inhibitor, from a Phase,2 trial in combination ... the 2008 Annual Meeting of the American,Society of Clinical ... 31 through June 3, 2008., Abstract 1027, titled, ...
... Spain, May 13 ,Boston Scientific Corporation (NYSE: ... the SPIRIT III clinical trial, which continue ... of the market-leading TAXUS(R) Express2(TM),Paclitaxel-Eluting Coronary Stent ... clinical evidence for the XIENCE(TM) V (PROMUS(TM)),Everolimus-Eluting ...
Cached Medicine Technology:Kosan Announces Data Presentations at ASCO 2008 Annual Meeting 2Kosan Announces Data Presentations at ASCO 2008 Annual Meeting 3SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents 2SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents 3SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents 4(Date:5/22/2013)... of Michigan study challenges previous research that suggests ... The study, a collaboration between researchers at U-M ... deeper into the controversial argument over whether MLB ... pitchers of the same race. It found little ... Winfree, associate professor of sport management at the ...
(Date:5/22/2013)... -- Over the next two decades, the cost of ... more than double, topping more than $180 billion a ... driving the increase: an aging population. The report, from ... Association, was published May 22 in the journal ... care system," Dr. Bruce Ovbiagele, chairman of the department ...
(Date:5/22/2013)... researchers report that hospitals may be reaping enormous ... by preventable bloodstream infections contracted in their intensive ... reported online in the American Journal of ... ICU patient who develops an avoidable central line-associated ... to care for than a similar infection-free patient. ...
(Date:5/22/2013)... May 22, 2013 Phelps Memorial Hospital ... Westchester Lung Nodule Center for individuals who would ... cancer care. Lung cancer is the deadliest form of cancer ... in the U.S. die from lung cancer than from breast, ... cancers, early detection increases survival rates. It is well ...
(Date:5/22/2013)... 22, 2013 Hurricane preparation isn’t just ... That’s why Amica Insurance is reminding everyone ... upcoming hurricane season. , “An important part of hurricane ... a senior assistant vice president at Amica Insurance. “The ... the threat of a storm.” , Flood damage is ...
Breaking Medicine News(10 mins):Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 3Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 3Health News:Reviewing Insurance Policies: a Key Part of Hurricane Preparations 2[0] U-M study challenges notion that umpires call more strikes for pitchers of same race[0] Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report[0] Hospitals profit when patients develop bloodstream infections[0] Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care[0] Reviewing Insurance Policies: a Key Part of Hurricane Preparations
... music industry,veteran and TV personality, is coming to ... about type 2 diabetes and its connection to,cardiovascular ... to speak on behalf of a national campaign, ... type 2 diabetes manage the disease,and reduce the ...
... ANSS ), a global innovator of simulation ... today announced it is a,sponsor of the Dinosaurs ... of,Natural History in Pittsburgh. This is the first ... immersive environments that are,composed of original fossil specimens. ...
... 17 NBTY, Inc. (NYSE:,NTY) (http://www.NBTY.com ), a ... that it will web cast the,presentation by Harvey Kamil, ... Small And Mid-Cap Conference in Las Vegas on,Wednesday, March ... web cast live on the Company Web,site, http://www.nbty.com ...
... chemokine receptor believed ... role in Crohn,s disease -, CAMBRIDGE, Mass., March 17 ... advancement of,MLN3126, a new product candidate, from the Company,s discovery ... CCR9, a,chemokine receptor known to be important in the migration ...
... Studies Now Available to the Public, ... Corporation,today announced the release of InSight(TM), a ... and sharpens the brain,s ability to process,visual ... just visual,processing abilities, but also increases driving ...
... Researchers will unveil a,new brain fitness ... in numerous,published studies to help people maintain ... of daily living tasks essential to,independence. The ... San,Francisco-based neuroscience company, will introduce the new ...
Cached Medicine News:Health News:Randy Jackson and the American Heart Association Educate Raleigh Area Residents About the Connection Between Type 2 Diabetes and Cardiovascular Disease 2Health News:Randy Jackson and the American Heart Association Educate Raleigh Area Residents About the Connection Between Type 2 Diabetes and Cardiovascular Disease 3Health News:ANSYS Sponsors Dinosaurs Exhibit at Carnegie Museum of Natural History 2Health News:ANSYS Sponsors Dinosaurs Exhibit at Carnegie Museum of Natural History 3Health News:NBTY to Web Cast Presentation at Citigroup Small and Mid-Cap Conference 2Health News:Millennium Expands IBD Franchise with Addition of New Development Candidate 2Health News:Millennium Expands IBD Franchise with Addition of New Development Candidate 3Health News:New Brain Training Program Improves Quality of Life 2Health News:New Brain Training Program Improves Quality of Life 3Health News:New Brain Fitness Training Promotes Health and Independence of Long Term Care Insurance Policyholders 2Health News:New Brain Fitness Training Promotes Health and Independence of Long Term Care Insurance Policyholders 3Randy Jackson and the American Heart Association Educate Raleigh Area Residents About the Connection Between Type 2 Diabetes and Cardiovascular DiseaseANSYS Sponsors Dinosaurs Exhibit at Carnegie Museum of Natural HistoryNBTY to Web Cast Presentation at Citigroup Small and Mid-Cap ConferenceMillennium Expands IBD Franchise with Addition of New Development CandidateNew Brain Training Program Improves Quality of LifeNew Brain Fitness Training Promotes Health and Independence of Long Term Care Insurance Policyholders
... EnVision Autoclavable Camera Head with an integrated coupler ... Made of a non-metallic material, it is cool ... just minutes. This product incorporates Smarthead technology allowing ... number of times the camera head has been ...
... 1-Chip Camera System provides easy-to-use features, auto ... scope. The camera head construction is based ... 14, Complete 1-Chip Camera System, International (GS ... Unit (CCU) with video cables , (GS ...
... offers 800+ lines of resolution along with color ... white balance features in a user-friendly design. , ... includes: , (GS 9923) Camera Control Unit (CCU) ... head with 3 meter cable (10 ft.)(1/2" format ...
Provides a combination of concentrated cold / hot and compression for the neck...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |